Nichol Ochsner
Investor Relations Contact presso ZEVRA THERAPEUTICS, INC.
Profilo
Nichol Ochsner is currently the VP-Investor Relations & Corporate Communications at Zevra Therapeutics, Inc. and is a member of the National Investor Relations Institute.
Previously, he worked as the Director-Corporate Communications at Medarex, Inc., Executive Director-IR & Corporate Communications at Old API Wind-down Ltd., VP-Investor Relations & Corporate Communications at TherapeuticsMD, Inc., and EVP-Investor Relations & Corporate Communications at Statera Biopharma, Inc. He obtained an undergraduate degree from West Virginia University.
Posizioni attive di Nichol Ochsner
| Società | Posizione | Inizio |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Investor Relations Contact | 09/08/2022 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Nichol Ochsner
| Società | Posizione | Fine |
|---|---|---|
| OLD API WIND-DOWN LTD. | Investor Relations Contact | 01/05/2018 |
| STATERA BIOPHARMA, INC. | Investor Relations Contact | - |
| THERAPEUTICSMD, INC. | Investor Relations Contact | - |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Public Communications Contact | - |
Formazione di Nichol Ochsner
| West Virginia University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| STATERA BIOPHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Nichol Ochsner
